An Evaluation of the In Vitro Roles and Mechanisms of Silibinin in Reducing Pyrazinamide- and Isoniazid-Induced Hepatocellular Damage
Tuberculosis remains a significant infectious lung disease that affects millions of patients worldwide. Despite numerous existing drug regimens for tuberculosis, drug-induced liver injury is a major challenge that limits the effectiveness of these therapeutics. Two drugs that form the backbone of th...
Main Authors: | Zhang-He Goh, Jie Kai Tee, Han Kiat Ho |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/10/3714 |
Similar Items
-
SIMULTANEOUS CONTENT ANALYSIS OF RIFAMPICIN, ISONIAZID, AND PYRAZINAMIDE IN TABLET DOSAGE FORM BY SPECTROPHOTOMETRY ULTRAVIOLET WITH DWM AND RSM
by: Muhammad Andry, et al.
Published: (2022-11-01) -
Development of a HPLC Method for Analysis of a Combination of Clofazimine, Isoniazid, Pyrazinamide, and Rifampicin Incorporated into a Dermal Self-Double-Emulsifying Drug Delivery System
by: Daniélle van Staden, et al.
Published: (2023-11-01) -
A comparative study on the adverse effects of two anti-tuberculosis drugs regimen in initial two-month treatment period
by: Begum Lutfun Nahar, A.K.M. Mosharrof Hossain, M. Monirul Islam and Dipti Rani Saha
Published: (2006-12-01) -
Hepatoprotective Effect of Aqueous Extract of Chichorium Intybus Roots on Isoniazid Induced Hepatotoxicity
by: Amanat Ali , Adnan Jehangir , Farhana Ayub
Published: (2016-09-01) -
Pharmacokinetics of antitubercular drugs in patients hospitalized with HIV-associated tuberculosis: a population modeling analysis [version 3; peer review: 1 approved, 2 approved with reservations]
by: Helen McIlleron, et al.
Published: (2024-03-01)